They found that genistein, a nature soybean flavonoid, is a neutral ligand for CB1 and can selectively bind to CB1.1 On the basis of this finding, the authors postulated that genistein can antagonize the effect of ∆9-THC induced endothelial dysfunctions. Here, CNR1 is linked to endothelial dysfunction.